201 related articles for article (PubMed ID: 32797761)
1. Anticholinergic medications and risk of dementia in older adults: Where are we now?
Chatterjee S; Talwar A; Aparasu RR
Expert Opin Drug Saf; 2020 Oct; 19(10):1251-1267. PubMed ID: 32797761
[TBL] [Abstract][Full Text] [Related]
2. Anticholinergic burden (prognostic factor) for prediction of dementia or cognitive decline in older adults with no known cognitive syndrome.
Taylor-Rowan M; Edwards S; Noel-Storr AH; McCleery J; Myint PK; Soiza R; Stewart C; Loke YK; Quinn TJ
Cochrane Database Syst Rev; 2021 May; 5(5):CD013540. PubMed ID: 34097766
[TBL] [Abstract][Full Text] [Related]
3. Anticholinergic burden for prediction of cognitive decline or neuropsychiatric symptoms in older adults with mild cognitive impairment or dementia.
Taylor-Rowan M; Kraia O; Kolliopoulou C; Noel-Storr AH; Alharthi AA; Cross AJ; Stewart C; Myint PK; McCleery J; Quinn TJ
Cochrane Database Syst Rev; 2022 Aug; 8(8):CD015196. PubMed ID: 35994403
[TBL] [Abstract][Full Text] [Related]
4. Association between Anticholinergic Medication Use and Risk of Dementia among Patients with Parkinson's Disease.
Sheu JJ; Tsai MT; Erickson SR; Wu CH
Pharmacotherapy; 2019 Aug; 39(8):798-808. PubMed ID: 31251824
[TBL] [Abstract][Full Text] [Related]
5. Association between using medications with anticholinergic properties and short-term cognitive decline among older men: A retrospective cohort study in Taiwan.
Wu YH; Wang CJ; Hung CH; Chen LY; Lin MH; Wang PN; Chen LK
Geriatr Gerontol Int; 2017 Apr; 17 Suppl 1():57-64. PubMed ID: 28436193
[TBL] [Abstract][Full Text] [Related]
6. Anticholinergics Influence Transition from Normal Cognition to Mild Cognitive Impairment in Older Adults in Primary Care.
Campbell NL; Lane KA; Gao S; Boustani MA; Unverzagt F
Pharmacotherapy; 2018 May; 38(5):511-519. PubMed ID: 29600808
[TBL] [Abstract][Full Text] [Related]
7. Cumulative use of strong anticholinergics and incident dementia: a prospective cohort study.
Gray SL; Anderson ML; Dublin S; Hanlon JT; Hubbard R; Walker R; Yu O; Crane PK; Larson EB
JAMA Intern Med; 2015 Mar; 175(3):401-7. PubMed ID: 25621434
[TBL] [Abstract][Full Text] [Related]
8. Anticholinergic medications in patients admitted with cognitive impairment or falls (AMiCI). The impact of hospital admission on anticholinergic cognitive medication burden. Results of a multicentre observational study.
Weichert I; Romero-Ortuno R; Tolonen J; Soe T; Lebus C; Choudhury S; Nadarajah CV; Nanayakkara P; Orrù M; Di Somma S;
J Clin Pharm Ther; 2018 Oct; 43(5):682-694. PubMed ID: 29729025
[TBL] [Abstract][Full Text] [Related]
9. Anticholinergics and clinical outcomes amongst people with pre-existing dementia: A systematic review.
Wang K; Alan J; Page AT; Dimopoulos E; Etherton-Beer C
Maturitas; 2021 Sep; 151():1-14. PubMed ID: 34446273
[TBL] [Abstract][Full Text] [Related]
10. Anticholinergic/Sedative Drug Burden and Subjective Cognitive Decline in Older Adults at Risk of Alzheimer's Disease.
Margolis SA; Kelly DA; Daiello LA; Davis J; Tremont G; Pillemer S; Denby C; Ott BR
J Gerontol A Biol Sci Med Sci; 2021 May; 76(6):1037-1043. PubMed ID: 32886748
[TBL] [Abstract][Full Text] [Related]
11. Anticholinergic Drug Burden and Risk of Incident MCI and Dementia: A Population-based Study.
Gildengers A; Stoehr GP; Ran X; Jacobsen E; Teverovsky E; Chang CH; Ganguli M
Alzheimer Dis Assoc Disord; 2023 Jan-Mar 01; 37(1):20-27. PubMed ID: 36706325
[TBL] [Abstract][Full Text] [Related]
12. Medication Profiles of Patients with Cognitive Impairment and High Anticholinergic Burden.
Green AR; Reifler LM; Boyd CM; Weffald LA; Bayliss EA
Drugs Aging; 2018 Mar; 35(3):223-232. PubMed ID: 29404965
[TBL] [Abstract][Full Text] [Related]
13. Anticholinergic drugs and incident dementia, mild cognitive impairment and cognitive decline: a meta-analysis.
Pieper NT; Grossi CM; Chan WY; Loke YK; Savva GM; Haroulis C; Steel N; Fox C; Maidment ID; Arthur AJ; Myint PK; Smith TO; Robinson L; Matthews FE; Brayne C; Richardson K
Age Ageing; 2020 Oct; 49(6):939-947. PubMed ID: 32603415
[TBL] [Abstract][Full Text] [Related]
14. AUGS Consensus Statement: Association of Anticholinergic Medication Use and Cognition in Women With Overactive Bladder.
This document was developed by the American Urogynecologic Society (AUGS) Guidelines Committee with the assistance of Tonya N. Thomas, MD, and Mark D. Walters, MD. This document reflects clinical and scientific advances as of the date issued and is subject to change. The information should not be construed as dictating an exclusive course of treatment or procedure to be followed. Its content is not intended to be a substitute for professional medical judgment, diagnosis, or treatment. The ultimate judgment regarding any specific procedure or treatment is to be made by the physician and patient in light of all circumstances presented by the patient.
Female Pelvic Med Reconstr Surg; 2017; 23(3):177-178. PubMed ID: 28441276
[TBL] [Abstract][Full Text] [Related]
15. Anticholinergic exposure and cognitive decline in older adults: effect of anticholinergic exposure definitions in a 3-year analysis of the multidomain Alzheimer preventive trial (MAPT) study.
Andre L; Gallini A; Montastruc F; Coley N; Montastruc JL; Vellas B; Andrieu S; Gardette V;
Br J Clin Pharmacol; 2019 Jan; 85(1):71-99. PubMed ID: 30098049
[TBL] [Abstract][Full Text] [Related]
16. Anticholinergic Burden and Cognitive Impairment in Nursing Homes: A Comparison of Four Anticholinergic Scales.
Novella A; Elli C; Ianes A; Pasina L
Drugs Aging; 2023 Nov; 40(11):1017-1026. PubMed ID: 37620654
[TBL] [Abstract][Full Text] [Related]
17. Relation Between Delirium and Anticholinergic Drug Burden in a Cohort of Hospitalized Older Patients: An Observational Study.
Pasina L; Colzani L; Cortesi L; Tettamanti M; Zambon A; Nobili A; Mazzone A; Mazzola P; Annoni G; Bellelli G
Drugs Aging; 2019 Jan; 36(1):85-91. PubMed ID: 30484239
[TBL] [Abstract][Full Text] [Related]
18. Anticholinergic Drug Use and Risk to Cognitive Performance in Older Adults with Questionable Cognitive Impairment: A Cross-Sectional Analysis.
Swami S; Cohen RA; Kairalla JA; Manini TM
Drugs Aging; 2016 Nov; 33(11):809-818. PubMed ID: 27638818
[TBL] [Abstract][Full Text] [Related]
19. How do cognitive and functional impairment relate to the use of anticholinergic medications in hospitalised patients aged 65 years and over?
Kusljic S; Woolley A; Lowe M; Manias E
Aging Clin Exp Res; 2020 Mar; 32(3):423-431. PubMed ID: 31124057
[TBL] [Abstract][Full Text] [Related]
20. Long-term anticholinergic use and the aging brain.
Cai X; Campbell N; Khan B; Callahan C; Boustani M
Alzheimers Dement; 2013 Jul; 9(4):377-85. PubMed ID: 23183138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
